Advanced Esophageal Cancer Clinical Trial
Official title:
An Open, Single-arm, Multicenter Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer
To evaluate the efficacy, safety and pharmacokinetic characteristics of HR070803 in the treatment of advanced esophageal cancer.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03706326 -
CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer
|
Phase 1/Phase 2 | |
Recruiting |
NCT05174156 -
Study on the Biomarker of First-line Immunotherapy Combined With Chemotherapy in Advanced Esophageal Cancer
|
Phase 2 | |
Completed |
NCT03691090 -
Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer
|
Phase 3 |